Quarterly report pursuant to Section 13 or 15(d)

Equity Incentive Plans and Stock-Based Compensation

v3.24.2.u1
Equity Incentive Plans and Stock-Based Compensation
6 Months Ended
Jun. 30, 2024
Share-Based Payment Arrangement [Abstract]  
Equity Incentive Plans and Stock-Based Compensation

Note 11. Equity Incentive Plans and Stock-Based Compensation

As of June 30, 2024, the Company had a remaining allocated reserve of 789,655 shares of its common stock for issuance under its 2021 Equity Incentive Plan (the “2021 EIP”), which provides for the granting of stock options, restricted stock units (“RSUs”) and stock appreciation rights to employees, directors, and consultants of the Company. As of June 30, 2024, the Company had an allocated reserve of 284,440 shares of its common stock for issuance under its 2021 Employee Stock Purchase Plan (“2021 ESPP”). As of June 30, 2024, the Company had not begun any offering periods for the 2021 ESPP.

Stock options

Activity under the 2021 EIP is set forth below:

 

 

Options

 

 

Weighted-
Average
Exercise
Price

 

 

Weighted-
Average
Remaining
Contractual
Term
in years

 

 

(In thousands)

 

 

(Per share data)

 

 

(Years)

 

Outstanding as of December 31, 2022

 

 

485

 

 

$

18.90

 

 

 

7.3

 

Granted

 

 

 

 

$

 

 

 

 

Exercised

 

 

(37

)

 

$

10.15

 

 

 

 

Forfeited or expired

 

 

(12

)

 

$

21.70

 

 

 

 

Outstanding as of June 30, 2023

 

 

436

 

 

$

19.95

 

 

 

7.4

 

Options vested and expected to vest as of June 30, 2023

 

 

436

 

 

$

19.95

 

 

 

 

Vested and exercisable as of June 30, 2023

 

 

330

 

 

$

23.10

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Outstanding as of December 31, 2023

 

 

376

 

 

$

21.47

 

 

 

6.2

 

Granted

 

 

 

 

$

 

 

 

 

Exercised

 

 

(51

)

 

$

6.30

 

 

 

 

Forfeited or expired

 

 

(13

)

 

$

28.43

 

 

 

 

Outstanding as of June 30, 2024

 

 

312

 

 

$

23.53

 

 

 

5.9

 

Options vested and expected to vest as of June 30, 2024

 

 

312

 

 

$

23.53

 

 

 

 

Vested and exercisable as of June 30, 2024

 

 

311

 

 

$

23.76

 

 

 

 

 

The aggregate intrinsic value of options outstanding was $2.0 million and $2.3 million, respectively, as of June 30, 2024 and December 31, 2023.

As of June 30, 2024, total unrecognized compensation cost related to options was immaterial and is expected to be recognized over a weighted-average period of 0.7 years.

For the six months ended June 30, 2024, there were no options granted.

Restricted Stock Units

The fair value of RSUs under the Company’s 2021 EIP is estimated using the value of the Company’s common stock on the date of grant.

The following table summarizes outstanding and expected to vest RSUs as of June 30, 2024 and 2023 and their activity during the six months ended June 30, 2024 and 2023:

 

 

Number
of Shares

 

 

Weighted-
Average
Grant Date
Fair Value

 

 

Aggregate
Intrinsic
Value

 

 

(In thousands)

 

 

(Per share data)

 

 

(In thousands)

 

Balance as of December 31, 2022

 

 

275

 

 

$

156.45

 

 

 

 

Granted

 

 

163

 

 

 

73.85

 

 

 

 

Released

 

 

(47

)

 

 

134.05

 

 

 

 

Cancelled

 

 

(41

)

 

 

149.45

 

 

 

 

Balance as of June 30, 2023

 

 

350

 

 

$

121.80

 

 

$

26,411

 

Expected to vest as of June 30, 2023

 

 

350

 

 

$

121.80

 

 

$

26,411

 

 

 

 

 

 

 

 

 

 

 

Balance as of December 31, 2023

 

 

570

 

 

$

68.00

 

 

 

 

Granted

 

 

137

 

 

$

8.30

 

 

 

 

Released

 

 

(83

)

 

$

81.54

 

 

 

 

Cancelled

 

 

(78

)

 

$

66.88

 

 

 

 

Balance as of June 30, 2024

 

 

546

 

 

$

51.13

 

 

$

1,812

 

Expected to vest as of June 30, 2024

 

 

546

 

 

$

51.13

 

 

$

1,812

 

 

The aggregate intrinsic value of outstanding RSUs is calculated based on the closing price of the Company’s common stock as of the date outstanding. As of June 30, 2024, there was $24.6 million of unrecognized compensation cost, which is expected to be recognized over a weighted average period of approximately 2.7 years. As of June 30, 2023, there was $37.3 million of unrecognized compensation cost, which is expected to be recognized over a weighted average period of approximately 2.7 years.

Earnout Shares–Employees

The Earnout Shares issuable to holders of employee stock options are accounted as stock-based compensation expense as they are subject to forfeiture based on the satisfaction of certain employment conditions. The estimated fair values of the Earnout Shares associated with vested stock options are recognized as an expense and determined by the Monte Carlo simulation valuation model using a distribution of potential outcomes on a monthly basis over the five-year earnout period. The portion of the Earnout Shares associated with unvested stock options are recognized as an expense and considers the vesting continuing employment requirements.

Stock-based Compensation Expense

The following sets forth the total stock-based compensation expense by type of award included in operating expenses on the statements of operations:

 

 

Three Months Ended
June 30,

 

 

Six Months Ended
June 30,

 

 

2024

 

 

2023

 

 

2024

 

 

2023

 

 

(In thousands)

 

Restricted stock units

 

$

3,101

 

 

$

4,745

 

 

$

6,930

 

 

$

8,803

 

Stock options

 

 

39

 

 

 

119

 

 

 

99

 

 

 

354

 

Earnout shares–employees

 

 

1,107

 

 

 

1,671

 

 

 

2,305

 

 

 

3,614

 

 

$

4,247

 

 

$

6,535

 

 

$

9,334

 

 

$

12,771

 

 

The following sets forth the total stock-based compensation expense for the stock options, RSUs, and earnout shares - employees included in cost of revenue and operating expenses on the statements of operations:

 

 

Three Months Ended
June 30,

 

 

Six Months Ended
June 30,

 

 

2024

 

 

2023

 

 

2024

 

 

2023

 

 

(In thousands)

 

Cost of 3D Printer

 

$

269

 

 

$

324

 

 

$

658

 

 

$

518

 

Cost of Support services

 

 

138

 

 

 

120

 

 

 

333

 

 

 

192

 

Research and development

 

 

1,130

 

 

 

2,835

 

 

 

2,680

 

 

 

5,638

 

Selling and marketing

 

 

862

 

 

 

1,585

 

 

 

1,916

 

 

 

3,081

 

General and administrative

 

 

1,848

 

 

 

1,671

 

 

 

3,747

 

 

 

3,342

 

 

$

4,247

 

 

$

6,535

 

 

$

9,334

 

 

$

12,771